Metabolomics insights into the causal associations between antihypertensive drugs and myocarditis
International Immunopharmacology · 2025-06 · 159 · 114946
DOI: 10.1016/j.intimp.2025.114946 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2025-06. Verfasst von Xinru Hu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, West China Hospital, Sichuan University, 37 Guoxue Street, Chengdu 610041, China. Hauptthemen laut MEDLINE: Antihypertensive Agents, Myocarditis, Hypertension. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: Sichuan University, West China Hospital, Sichuan University.
Abstract (Originalsprache)
BACKGROUND: The role of various antihypertensive drug classes in myocarditis remains unclear. We aimed to investigate the causal effects of antihypertensive medications on myocarditis and identify potential metabolic pathways. METHODS: We extracted single-nucleotide polymorphisms for systolic blood pressure (SBP) and diastolic BP (DBP) from a genome-wide association study (N = 757,601) and screened single-nucleotide polymorphisms associated with angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, β-blockers (BB), calcium channel blockers (CCB), and thiazides as instrumental variables. Summary-level statistics of myocarditis were sourced from the FinnGen study, encompassing 1847 cases and 231,952 controls. We subsequently performed a drug-targeted Mendelian randomization (MR) and a two-step network MR approach to investigate the causal impact of antihypertensive medications on myocarditis and to uncover metabolic mediators. RESULTS: Our study revealed that elevated SBP (odds ratio [OR] = 1.05, 95 % confidence interval [CI] = 1.04-1.06, p = 4.75 × 10-14) and DBP (OR = 1.07, 95 % CI = 1.05-1.10, p = 1.54 × 10-10) significantly increased myocarditis risk. Conversely, the use of BB (OR = 0.86, 95 % CI = 0.82-0.90, p = 5.14 × 10-10) and CCB (OR = 0.95, 95 % CI = 0.92-0.99, p = 0.005) to lower BP was associated with a reduced risk of myocarditis. Network MR analyses identified four and seven metabolites mediating BB and CCB associations with myocarditis, respectively. Methyl indole-3-acetate mediated a significant portion of the relationships between BB and myocarditis (mediation proportion = 6.82 %), while phenylalanine to tyrosine ratio was the predominant mediator (mediation proportion = 11.35 %) linking CCB to myocarditis. CONCLUSIONS: Our findings suggest that reducing BP through antihypertensive drugs, specifically BB and CCB, may hold potential for preventing myocarditis and have identified several metabolic pathways linking these associations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, West China Hospital, Sichuan University, 37 Guoxue Street, Chengdu 610041, China.
- Department of Cardiology, West China Hospital, Sichuan University, 37 Guoxue Street, Chengdu 610041, China. Electronic address: pengyong@scu.edu.cn.
Förderung
- Sichuan University
- West China Hospital, Sichuan University
Zitieren
APA
Hu, X., Hu, T., Ye, Y., Chen, X., Abulikemu, S., Yu, J., Zhao, Y., Wang, J., & Peng, Y. (2025). Metabolomics insights into the causal associations between antihypertensive drugs and myocarditis. International Immunopharmacology, 159, 114946. https://doi.org/10.1016/j.intimp.2025.114946
Vancouver
Hu X, Hu T, Ye Y, Chen X, Abulikemu S, Yu J, et al. Metabolomics insights into the causal associations between antihypertensive drugs and myocarditis. International Immunopharmacology. 2025;159:114946. doi:10.1016/j.intimp.2025.114946
BibTeX
@article{Hu2025,
author = {Hu, Xinru and Hu, Teng and Ye, Yuyang and Chen, Xuefeng and Abulikemu, Simayi and Yu, Jiang and Zhao, Yifei and Wang, Junwen and Peng, Yong},
title = {Metabolomics insights into the causal associations between antihypertensive drugs and myocarditis},
journal = {International Immunopharmacology},
year = {2025},
volume = {159},
pages = {114946},
doi = {10.1016/j.intimp.2025.114946}
}
EUVIMED